CTRI/2019/01/017275已完成3 期
Comparative efficacy of levosimendan versus milrinone in patients with severe pulmonary hypertension undergoing elective mitral valve replacement surgery - A randomized study
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- one
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Patients of either sex
- •2 Age betwwen 18 to 70 year
- •3 Mitral valve disease
- •4 Severe pulmonary hypertension (Right ventricular systolic pressure more than or equals to 50 mm Hg)
- •5 Scheduled for elective mitral valve replacement surgery
排除标准
- •1 Presence of concurrent coronary artery disease. Patients more than 45yr old will have coronary angiography done to rule out coronary artery disease.
- •2 Coexisting aortic valve disease
- •3 Patients in NYHA IV
- •4 Patients requiring pre-operative inotropes
- •5 Pregnancy
- •6 Coexisting hepatic, renal or severe respiratory disease
研究者
相似试验
招募中
不适用
Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal InsufficiencyLevosimendanMilrinoneHeart FailureEfficacySafetyNCT06205758Yi Han1,600
尚未招募
4 期
Study to show which is better for oxygen delivery & blood flow among levosimendan or milrinone in coronary artery surgeriesCTRI/2024/02/063388INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH
Unknown
4 期
Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic ShockSeptic ShockCardiomyopathyNCT02640846Sahlgrenska University Hospital, Sweden30
进行中（未招募）
1 期
Evaluation of a new therapeutic strategy with levosimendan use in the treatment of acute and severe heart failure.MedDRA version: 20.0Level: PTClassification code 10007625Term: Cardiogenic shockSystem Organ Class: 10007541 - Cardiac disordersCardiogenic shockEUCTR2019-001563-74-FRCHRU de Nancy610
进行中（未招募）
1 期
Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock.Cardiogenic ShockCTIS2024-513811-29-00CHRU De Nancy610